HomeNewsWorldAir travel demand 'normalising' after COVID boom, execs say

Air travel demand 'normalising' after COVID boom, execs say

Air India CEO Campbell Wilson said he expected the international market to moderate for the next six months, while the CEO of BA-owner IAG ICAG.L, Luis Gallego, said business travel was still recovering from the COVID crisis when travel almost ground to a halt with borders shut and planes grounded.

July 22, 2024 / 19:08 IST
Story continues below Advertisement
The executives lamented ongoing delivery delays from planemakers Airbus AIR.PA and Boeing BA.N, as well as supply chain constraints.
The executives lamented ongoing delivery delays from planemakers Airbus AIR.PA and Boeing BA.N, as well as supply chain constraints.

Demand for air travel has normalised after a years-long boom following the COVID-19 pandemic as holidaymakers and travellers baulk at higher fares, executives at major airlines said at the Farnborough Airshow on Monday.

Guliz Ozturk, CEO of Turkey's low-cost Pegasus Airlines PGSUS.IS, said the airline expected yields - a measure of average fare paid per mile by each passenger - to be flat as customers go "back to basics".

Story continues below Advertisement

Travellers are looking for the most cost effective way to travel, she said.

"We have started seeing the normalisation of demand. What does it mean? I mean, the demand is there, but now the travellers are looking for, as before the pandemic, for the most affordable, the lowest, the best price for their travel," she said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show